Assenagon Asset Management S.A. View Ray, Inc. Transaction History

Assenagon Asset Management S.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$0.35 - $3.28 $127,602 - $1.2 Million	-364,580 Reduced 95.83%	15,859 $5,000
Q1 2023 Apr 18, 2023	BUY	$3.28 - $4.81 $419,862 - $615,713	128,007 Added 50.71%	380,439 $1.32 Million
Q4 2022 Jan 12, 2023	BUY	$3.65 - $4.82 $921,376 - $1.22 Million	252,432 New	252,432 $1.13 Million
Q2 2022 Jul 27, 2022	BUY	$2.42 - $4.05 $4.44 Million - $7.43 Million	1,835,355 New	1,835,355 $4.86 Million
Q2 2021 Jul 15, 2021	SELL	$3.94 - $6.75 $1.29 Million - $2.21 Million	-327,200 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$4.03 - $7.25 $1.32 Million - $2.37 Million	327,200 New	327,200 $1.42 Million
Q2 2019 Aug 12, 2019	SELL	$6.7 - $9.13 $3.07 Million - $4.18 Million	-458,162 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$5.7 - $8.73 $2.61 Million - $4 Million	458,162 New	458,162 $3.39 Million

645K

50K

30K

Ticker VRAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 181,010,000
Market Cap $1.81M
Description
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.